Queen's Gambit Growth Capital (GMBT) Stock Price, News & Analysis

Company Overview

Queen's Gambit Growth Capital, a blank check company, intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $9.10 to $9.95
• 50-Day Range: $9.38 to $9.96
• 52-Week Range: $9.10 to $10.24
• Volume: 201,795 shs
• Average Volume: 240,808 shs
• Market Capitalization: $351.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GMBT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Queen's Gambit Growth Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Queen's Gambit Growth Capital investors own include ADMA Biologics (ADMA), ImmunityBio (IBRX), GlobalFoundries (GFS), Duolingo (DUOL), Docusign (DOCU) and CrowdStrike (CRWD).

Company Calendar

• Today: 7/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GMBT
• CIK: 1836190
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 37,500,000
• Free Float: N/A
• Market Cap: $351.75 million
• Optionable: Not Optionable
• Beta: N/A